Does USTEKINUMAB Cause Product use issue? 5,008 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5,008 reports of Product use issue have been filed in association with USTEKINUMAB (PYZCHIVA). This represents 5.9% of all adverse event reports for USTEKINUMAB.
5,008
Reports of Product use issue with USTEKINUMAB
5.9%
of all USTEKINUMAB reports
729
Deaths
1,670
Hospitalizations
How Dangerous Is Product use issue From USTEKINUMAB?
Of the 5,008 reports, 729 (14.6%) resulted in death, 1,670 (33.3%) required hospitalization, and 1,033 (20.6%) were considered life-threatening.
Is Product use issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for USTEKINUMAB. However, 5,008 reports have been filed with the FAERS database.
What Other Side Effects Does USTEKINUMAB Cause?
Drug ineffective (12,471)
Off label use (10,990)
Product dose omission issue (9,405)
Fatigue (5,457)
Psoriasis (4,955)
Pain (4,872)
Rash (4,736)
Crohn's disease (4,662)
Arthralgia (4,608)
Infusion related reaction (4,471)
What Other Drugs Cause Product use issue?
INFLIXIMAB (12,752)
DUPILUMAB (10,575)
POLYETHYLENE GLYCOL 3350 (9,432)
METHOTREXATE (8,185)
DICLOFENAC (8,009)
RITUXIMAB (6,948)
ADALIMUMAB (6,379)
ETANERCEPT (6,062)
TOCILIZUMAB (5,944)
ABATACEPT (5,915)
Which USTEKINUMAB Alternatives Have Lower Product use issue Risk?
USTEKINUMAB vs USTEKINUMAB-STBA
USTEKINUMAB vs VADADUSTAT
USTEKINUMAB vs VALACYCLOVIR
USTEKINUMAB vs VALBENAZINE
USTEKINUMAB vs VALBENAZINE DITOSYLATE